Lung cancer screening in risk groups
Institute for General Practice and Evidence-based Health Services Research, Medical University of Graz (IAMEV)
Record ID 32018001178
Authors' objectives: The aim of this EUnetHTA Assessment is to provide a reliable synthesis and analysis of the available evidence on lung cancer screening in risk groups (persons with history of smoking or current smokers, persons with occupational or environmental exposure to radon, asbestos or fine particles, patients with COPD or idiopathic pulmonary fibrosis, or persons with a family history of lung cancer). Research question 1: What is the benefit/harm of screening for lung cancer using low-dose computed tomography (LDCT) compared to no (or no systematic) screening in individuals at elevated risk of lung cancer? As there is reason to assume comparability of no screening and screening using chest X-ray, screening for lung cancer using chest X-ray will be taken into account as a comparator, too if reasonable. Research question 2: What is the benefit/harm of screening for lung cancer using biomarkers in addition to LDCT compared to screening using LDCT alone in individuals at elevated risk of lung cancer? Research question 3: What is the benefit/harm of organizational variations of systematic screening for lung cancer using LDCT (e.g. screening with different intervals, with/without invitation) in individuals at elevated risk of lung cancer? Research question 4: What is the best strategy to inform individuals in the target group about a lung cancer screening program to optimize an informed choice regarding participation?
Project Status: Completed
URL for project: https://eunethta.eu/otca28/
Year Published: 2020
URL for published report: https://eunethta.eu/otca28/
Requestor: HTA agencies
English language abstract: An English language summary is available
Publication Type: Rapid Review
- Lung Neoplasms
- Mass Screening
- Early Detection of Cancer
- Pulmonary Disease, Chronic Obstructive
- Idiopathic Pulmonary Fibrosis
- Occupational Exposure
- Risk Factors
Organisation Name: European Network for Health Technology Assessment
Contact Email: firstname.lastname@example.org
Copyright: CC-BY-NC: You may copy, distribute, display, perform, and modify and use the EUnetHTA work for any purpose other than commercially unless you get your permission first.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.